Summarizing Bio-Europe 2025
Innovating in cancer R&D - together. Three days in Vienna full of meetings, presentations, panels, and discussions to create partnerships that matter to drive innovation.
)
Indivumed at Bio-Europe 2025Where partnering becomes the science of connection
Three incredible days packed with meetings, presentations, panels, and discussions in a buzzing hall full of energy with thousands of participants. We met inspiring new people and companies, strengthened existing partnerships, and kicked off exciting new collaborations.
Most importantly, we gained valuable insights into pharma needs that confirm: we’re on the right track.
Highly motivated, we intensify our efforts in large and small molecule developments - driving forward cancer therapeutics that truly make a difference.
On stage at Bio-Europe 2025Review two panel discussions that shape the future of biopharma
Our CEO and our CBO joined other industry experts on stage to share perspectives on the trends redefining partnerships and innovation. From M&A strategies to the evolving role of strategic services, these sessions brought together thought leaders and created insightful discussions on stage.
)
)
)
Partner with usCollaborations that drive innovation
Science alone isn’t enough. Bringing cancer therapeutics to patients requires the right partners. You have not been on site but want to learn more about our small molecule program IN-2401, a first-in-class opportunity in colorectal cancer? Or explore our work on surfaceome tumor antigens? We're also ready to co-create entirely new pipelines from scratch.